Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia.

Alzheimers Dement (Amst) · 2025 · PMC12140970 · PMID 40487537

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep > 0.06so close (0.05 < p ≤ 0.1)

Each participant with matched pairs showed a reduction in CSF BD‐tau levels, although due to the small sample size the group average change did not reach statistical significance ( p > 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.